| 摘要 |
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to oncology, and aims at treatment of cancer. N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2-ilcarbonylamino] ethoxy}benzamide of formula (I):or its salt connection with a pharmaceutically acceptable acid or base, separately or in combination with the surgical intervention, chemotherapy, hormonal therapy or radiation therapy is administered for 4 days running, followed by 3 days running without using said compound, at the same time chemotherapy is not FOLFOX.EFFECT: invention ensures increased human cancer treatment efficiency.10 cl, 2 dwg |
